Brizuela L - Search Results

1

Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.

Cuvillier O, Ader I, Bouquerel P, Brizuela L, Malavaud B, Mazerolles C, Rischmann P. Cuvillier O, et al. Among authors: brizuela l. Curr Mol Pharmacol. 2010 Jun;3(2):53-65. doi: 10.2174/1874467211003020053. Curr Mol Pharmacol. 2010. PMID: 20302564 Review.

2

Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide.

Gomez-Brouchet A, Pchejetski D, Brizuela L, Garcia V, Altié MF, Maddelein ML, Delisle MB, Cuvillier O. Gomez-Brouchet A, et al. Among authors: brizuela l. Mol Pharmacol. 2007 Aug;72(2):341-9. doi: 10.1124/mol.106.033738. Epub 2007 May 23. Mol Pharmacol. 2007. PMID: 17522181

3

Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells.

Ader I, Brizuela L, Bouquerel P, Malavaud B, Cuvillier O. Ader I, et al. Among authors: brizuela l. Cancer Res. 2008 Oct 15;68(20):8635-42. doi: 10.1158/0008-5472.CAN-08-0917. Cancer Res. 2008. PMID: 18922940

4

Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.

Guillermet-Guibert J, Davenne L, Pchejetski D, Saint-Laurent N, Brizuela L, Guilbeau-Frugier C, Delisle MB, Cuvillier O, Susini C, Bousquet C. Guillermet-Guibert J, et al. Among authors: brizuela l. Mol Cancer Ther. 2009 Apr;8(4):809-20. doi: 10.1158/1535-7163.MCT-08-1096. Mol Cancer Ther. 2009. PMID: 19372554

5

Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.

Dayon A, Brizuela L, Martin C, Mazerolles C, Pirot N, Doumerc N, Nogueira L, Golzio M, Teissié J, Serre G, Rischmann P, Malavaud B, Cuvillier O. Dayon A, et al. Among authors: brizuela l. PLoS One. 2009 Nov 26;4(11):e8048. doi: 10.1371/journal.pone.0008048. PLoS One. 2009. PMID: 19956567 Free PMC article.

6

The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer.

Brizuela L, Dayon A, Doumerc N, Ader I, Golzio M, Izard JC, Hara Y, Malavaud B, Cuvillier O. Brizuela L, et al. FASEB J. 2010 Oct;24(10):3882-94. doi: 10.1096/fj.10-160838. Epub 2010 Jun 3. FASEB J. 2010. PMID: 20522783

7

FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O. Pchejetski D, et al. Among authors: brizuela l. Cancer Res. 2010 Nov 1;70(21):8651-61. doi: 10.1158/0008-5472.CAN-10-1388. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959468 Free article.

8

Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate.

Brizuela L, Cuvillier O. Brizuela L, et al. Methods Mol Biol. 2012;874:1-20. doi: 10.1007/978-1-61779-800-9_1. Methods Mol Biol. 2012. PMID: 22528435

9

First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.

Brizuela L, Ader I, Mazerolles C, Bocquet M, Malavaud B, Cuvillier O. Brizuela L, et al. Mol Cancer Ther. 2012 Sep;11(9):1841-51. doi: 10.1158/1535-7163.MCT-12-0227. Epub 2012 Jul 10. Mol Cancer Ther. 2012. PMID: 22784711

10

Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.

Cuvillier O, Ader I, Bouquerel P, Brizuela L, Gstalder C, Malavaud B. Cuvillier O, et al. Among authors: brizuela l. Adv Cancer Res. 2013;117:117-41. doi: 10.1016/B978-0-12-394274-6.00005-4. Adv Cancer Res. 2013. PMID: 23290779 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters